BusinessAbCellera and Merck Sign Novel Therapeutic Antibody Discovery CollaborationBy Nasdaq OMXJan 27, 2016, 9:08 PM UTC
BusinessAbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola VirusBy Nasdaq OMXJan 21, 2016, 12:14 AM UTC
